PerspectiveAlzheimer’s Disease

Rapamycin and Alzheimer’s disease: Time for a clinical trial?

See allHide authors and affiliations

Science Translational Medicine  23 Jan 2019:
Vol. 11, Issue 476, eaar4289
DOI: 10.1126/scitranslmed.aar4289

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article